The final stage of World Architecture News’s deep dive into Perkins&Will’s portfolio will see the team speak to Ryan Bussard, Principal, Design Director, to discover how the firm deviated from traditional laboratory design for its US cancer research facility, Center for Novel Therapeutics.
Collegial collaboration was at the heart of this hybrid project, which features floating meeting rooms and a central “living room” space. Watch it come together and discover the highlights and lessons learned from the overall process.
Timings to be announced soon.